2005
Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
Bizzarro M, Gross I. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. 2005, cd005055. PMID: 16235391, DOI: 10.1002/14651858.cd005055.pub2.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsMean pulmonary arterial pressurePulmonary hypertensive crisisCongenital heart diseaseLong-term mortalityHeart diseasePulmonary hypertensionHeart rateHospital stayArterial pressureNitric oxidePostoperative managementMethodologic qualityMethaemoglobin levelsNeurodevelopmental disabilitiesEfficacy of iNOUse of iNOCochrane Central RegisterPulmonary arterial pressureSystemic blood pressureSubgroup of patientsHigh methodologic qualityMajority of outcomesMarkers of toxicityConventional managementHypertensive crisis
2004
Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease
Bizzarro M, Gross I. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. 2004 DOI: 10.1002/14651858.cd005055.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements